KTVU - Treating breast cancer has long involved addressing two problems: eliminating cancer cells from the tumor and preventing the disease from returning. Experts say the key may be to stimulate and strengthen the body's immune system to do both jobs. Researchers at the Mayo Clinic in Florida announced they are working on a new anti-cancer vaccine to help the body resist the return of "triple-negative breast cancer," an aggressive form of breast cancer that is more likely to spread beyond the breast and more likely to come back after treatment.
The Breast Cancer SPORE supports four translational research projects that generate advances in the understanding of breast cancer biology. Three cores support research in the Breast Cancer SPORE through administrative services, biospecimens and pathology, and data management. The Developmental Research Program funds new research projects and the Career Enhancement Program mentors promising investigators.
Metastatic breast cancer is a leading cause of morbidity and mortality that needs to be understood and conquered. Therapy for metastatic breast cancer remains palliative. The average survival time after the diagnosis of metastatic breast cancer is 24 months, although it varies widely according to the metastatic site, biological characteristics, patient condition and treatment .
Mayo Clinic to support clinical trial development and oversee Imago's reader studies for mammography. August 14, — Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year agreement will focus on clinical trial support for Imago Systems' ICE Reveal product for breast imaging and includes financial investment from Mayo Clinic.
Tens of thousands of women die annually from breast cancer, but soon, the number could decrease. Mayo Clinic in Jacksonville is working on a vaccine for triple negative breast cancer that could someday save millions. While the vaccine is still in clinical trials, doctors say they are very excited because early results indicate it seems to be working with few negative side effects.
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. This content does not have an English version.
October 16, Treating breast cancer has long involved addressing two problems: the elimination of cancer cells from the tumor and potential disease recurrence. The key may be to harness the full capabilities of the body's immune system to do both jobs.
Matthew P. Goetz, M. The vision of this second renewal of the Mayo Clinic Breast Cancer SPORE is that the burden of breast cancer can be reduced through the performance of innovative translational research accomplished by addressing research questions of high significance for women. The Breast SPORE research portfolio has been developed with a balance of research projects that maximizes the impact of the research and provides the greatest likelihood of realizing the vision.
McLaughlin, M. Radisky, Ph. Research is organized around two central initiatives: prevention, which includes immunotherapy vaccines, people with a high risk of breast cancer and survivorship; and precision medicine, which includes novel targeted therapeutics, genetic profiling and experimental trials.
Rochester, Minn. Under the multiyear agreement, Mayo Clinic will provide financial backing to help Imago develop technology for breast imaging analysis. Additionally, Mayo Clinic researchers will lead and participate in clinical studies to validate the software, which aims to detect early-stage breast cancer in mammograms and other imaging data.